No, sevelamer is NOT calcium-based
Sevelamer (Renvela, Renagel) is explicitly a non-calcium-based phosphate binder. It is a polymeric amine that binds phosphate in the gastrointestinal tract without containing any calcium, metal, or aluminum 1.
Chemical Composition
Sevelamer is available in two formulations:
- Sevelamer hydrochloride (Renagel) - uses chloride as the counterion
- Sevelamer carbonate (Renvela) - uses carbonate as the counterion
Both formulations contain the same active polymer that binds phosphate, but neither contains calcium 1. The FDA label explicitly states that Renvela contains "sevelamer carbonate, a non-absorbed phosphate binding crosslinked polymer, free of metal and calcium" 1.
Clinical Distinction from Calcium-Based Binders
The K/DOQI guidelines consistently distinguish sevelamer as a "noncalcium-, nonaluminum-, and nonmagnesium-containing phosphate-binding agent" and recommend it as an alternative when calcium-based binders (like calcium carbonate or calcium acetate) are contraindicated 2.
Key clinical differences:
- Sevelamer does not contribute to calcium load, reducing hypercalcemia risk 2, 3, 2
- Guidelines recommend sevelamer when total elemental calcium intake from calcium-based binders exceeds 2,000 mg/day 2
- Sevelamer is preferred in patients with severe vascular calcification, where calcium-based binders may worsen calcification 3
The evidence consistently shows that sevelamer-treated patients have significantly fewer hypercalcemic episodes compared to those on calcium-based binders (5% vs 16% in one trial) 3.